These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16112793)

  • 1. Bone turnover in young hypoestrogenic women on hormonal therapy.
    Chan CC; Tang OS; Lau WN; Tang GW
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):204-6. PubMed ID: 16112793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Holinka CF; Christiansen C; Tian XW; Ausmanas MK
    Climacteric; 2008 Feb; 11(1):44-54. PubMed ID: 18202964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Holinka CF; Ling YS; Christiansen C
    Climacteric; 2007 Aug; 10(4):306-13. PubMed ID: 17653957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women.
    Prestwood KM; Gunness M; Muchmore DB; Lu Y; Wong M; Raisz LG
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2197-202. PubMed ID: 10852452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short-term effects of conjugated estrogen on bone turnover in older women.
    Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
    Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
    Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis.
    Hadji P; Ryan KA; Yu CR; Mirkin S; Komm BS
    Climacteric; 2016 Oct; 19(5):482-7. PubMed ID: 27631562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changes in plasma serotonin levels after hormone therapy and their relationship with estrogen responsiveness on bone in postmenopausal women.
    Kim HY; Park MH; Yoon HK; Han KO
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1986-94. PubMed ID: 22442273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.
    Greenspan SL; Resnick NM; Parker RA
    J Clin Endocrinol Metab; 2005 May; 90(5):2762-7. PubMed ID: 15713726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT.
    Rosen HN; Parker RA; Greenspan SL; Iloputaife ID; Bookman L; Chapin D; Perlmutter I; Kessel B; Qvist P; Rosenblatt M
    Calcif Tissue Int; 2004 May; 74(5):415-23. PubMed ID: 14961215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
    Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women.
    De Leo V; Ditto A; la Marca A; Lanzetta D; Massafra C; Morgante G
    Calcif Tissue Int; 2000 Apr; 66(4):263-7. PubMed ID: 10742442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study.
    Wimalawansa SJ
    J Bone Miner Res; 2000 Nov; 15(11):2240-4. PubMed ID: 11092405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.